Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
IL-18BP (human) (monomeric):Fc (LALA-PG)-KIH (human) (rec.) - InVivoKine™

Product Details | |
---|---|
Synonyms | Interleukin-18-binding Protein (human) (monomeric):Fc (LALA-PG) Knobs-into-Holes (human) (rec.); Interferon gamma-inducing Factor-binding Protein; Tadekinig-alfa |
Product Type | Protein |
Properties | |
Source/Host | HEK 293 cells. Produced using animal component-free medium. |
Sequence |
Human IL-18BP (aa 31-194) is fused at the C-terminus to the Fc portion of human IgG1 (LALA-PG) (Knobs-into-Holes technology) (see reference: J.B. Ridgway, et al.; Protein Eng. 9, 617 (1996)). |
Crossreactivity | Human |
Specificity |
Binds to human IL-18. Fc (LALA-PG)-KIH (human) does not bind to FcRs. |
MW | ~70kDa and 28kDa (SDS-PAGE) |
Purity | ≥95% (SDS-PAGE) |
Endotoxin Content | <0.01EU/μg protein (LAL test). |
Concentration | After reconstitution: 1mg/ml |
Reconstitution | Reconstitute with 50μl endotoxin-free water. |
Accession Number | O95998 |
Formulation | Lyophilized. Contains PBS. |
Protein Negative Control |
Fc (LALA-PG)-KIH (human) IgG1 Control (rec.) (Prod. No. AG-35B-0018) |
Other Product Data |
Uniprot link O95998: IL-18BP (human) |
Shipping and Handling | |
Shipping | BLUE ICE |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice |
After reconstitution, prepare aliquots and store at -20°C. Avoid freeze/thaw cycles. Centrifuge lyophilized vial before opening and reconstitution. PBS containing at least 0.1% BSA should be used for further dilutions. |
Use/Stability |
Stable for at least 6 months after receipt when stored at -20°C. Working aliquots are stable for up to 3 months when stored at -20°C. |
Documents | |
Product Specification Sheet | |
Datasheet |
![]() |
IL-18, initially named interferon-γ inducing factor (IGIF) is an IL-1 family member and a cytokine that links innate and adaptive immunity. Depending on the microenvironment and timing, IL-18 can either drive harmful inflammation or restore immune homeostasis.
IL-18 is regulated i) by the inflammasome that converts the inactive pro-IL-18 to its active form IL-18; ii) by the cytokine it induces, the master cytokine IFN-γ that triggers the expression of the inhibitor of IL-18, called IL-18 binding protein (IL-18BP). IL-18 binding protein (IL-18BP) is one of only four natural cytokine antagonists. IL-18BP has an exceptionally high affinity for IL-18 and its slow dissociation rate makes it an effective regulator of IL-18, essential for maintaining immune balance and influencing disease outcomes.
The protein IL-18BP (human) (monomeric):Fc (LALA-PG)-KIH (human) (rec.) is produced by using two different vectors, one encoding for the IL-18BP (human):Fc (LALA-PG) Knobs sequence (synthesizing a protein of 70kDa) and one encoding for the Fc (LALA-PG) Holes sequence (synthesizing a protein of 28kDa). Both vectors transfected into HEK293 cells produce both Fc molecules (Knobs-into-Holes technology; J.B. Ridgway, et al.; Protein Eng. 9, 617 (1996)) required for dimerization of the Fc moieties and for secretion of the final protein IL-18BP (human) (monomeric):Fc-KIH (human) (rec.). The LALA-PG mutations inhibit binding to FcγRs and C1q while FcRn binding and Fc stability remain unaffected.
InVivoKines™ are a new generation of recombinant fusion proteins for immunotherapeutic, preclinical, and translational in vivo research, developed and manufactured by AdipoGen Life Sciences.